When was C the Signs founded?

C the Signs was founded in 2016 and raised its 1st funding round 1 year after it was founded.

Where is C the Signs located?

C the Signs is headquartered in London, United Kingdom.

Who is the current CEO of C the Signs?

Bhavagaya Bakshi of C the Signs. They have also founded 1 company.

Which legal entities is C the Signs associated with?

C the Signs is associated with C The Signs Limited.

How many employees does C the Signs have?

As of Aug 31, 2026, the latest employee count at C the Signs is 41.

Is C the Signs a funded company?

C the Signs is a funded company, having raised a total of $14.9M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Aug 27, 2017.

How much is C the Signs worth?

The latest valuation of C the Signs is £***** as of Oct 19, 2021.

When was the latest funding round of C the Signs?

C the Signs' latest funding was a $***** Series A round on Jan 30, 2025, with participation from 1 investor.

Where does C the Signs rank among its competitors?

C the Signs ranks 4th amongst 29 active competitors, of which 9 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Nanovery, which secured $1.47M in Apr, 2025.

Who are the top competitors of C the Signs?

C the Signs' top competitors include Prenuvo, IdentifySensors and Nanovery. Among them, Nanovery secured the most recent funding round in April, 2025.

C the Signs - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Platform offering cancer prediction system for early cancer detection. The platform analyzes data to identify patients at risk of cancer at the earliest and curable stage of the disease. It offers a range of services, including cancer prevention, screening, point of care cancer assessment, and surveillance. It uses a data driven approach to identify patients at risk of cancer, combining risk factors such as signs, symptoms, clinical markers, genetics, lifestyle, and environmental factors.

Website: www.cthesigns.com/
Social
Email ID: *****@cthesigns.co.uk

Key Metrics

Founded Year

2016

Location

London, United Kingdom

Stage

Series A

Total Funding

$14.9M in 4 rounds

Latest Funding Round

Series A, Jan 30, 2025, $*****

Post Money Valuation

£***** as on Oct 19, 2021

Investors

Khosla Ventures & 1 more

Ranked

4^th among 29 active competitors

Employee Count

41 as on Aug 31, 2026

Similar Companies

Prenuvo & 30 more

View C the Signs' full profile

C the Signs is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
C The Signs Limited CIN: 10683539 , United Kingdom, Active	Mar 21, 2017	-	24 (As on Mar 31, 2024)

C the Signs has raised a total funding of $14.9M over 4 rounds. Its first funding round was on Aug 27, 2017. Its latest funding round was a Series A round on Jan 30, 2025 for $*****. 1 investor participated in its latest round. C the Signs has 2 institutional investors.

Here is the list of recent funding rounds of C the Signs:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 30, 2025	1939094	Series A	8804465	5539322	5149202	2703605
Oct 19, 2021	1703341	Series A	2621694	5597695	2101053	6100365
2021	3786	Series A	9176	9513	1743	MMC Ventures

Access funding benchmarks and valuations. Sign up today!

View details of C the Signs's funding rounds and investors

The founders of C the Signs are Miles Payling and Bhavagaya Bakshi. Bhavagaya Bakshi is the CEO of C the Signs.

Here are the details of C the Signs' key team members:

Miles Payling: Co-Founder & Chief Scientific Officer of C the Signs and founder of 1 other company.
Contact Info: 2 email addresses
Bhavagaya Bakshi: Co-Founder & CEO of C the Signs and founder of 1 other company.
Contact Info: 1 email address

View details of C the Signs's Founder profiles and Board Members

C the Signs' employee count trend

C the Signs has 41 employees as of Aug 26. Here is C the Signs's employee count trend over the years:

Uncover C the Signs' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of C the Signs include Prenuvo, IdentifySensors and Nanovery. Here is the list of Top 10 competitors of C the Signs, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Prenuvo 2018, San Francisco (United States), Series C	Provider of MRI and other screening services	$275M	Forerunner Ventures, Felicis Ventures & 10 others	57/100
2nd	IdentifySensors 2006, Shaker Heights (United States), Series B	Provider of bio-sensors for real-time detection of materials and chemicals harmful to humans	$22.1M	-	51/100
3rd	Nanovery 2018, London (United Kingdom), Seed	Developer of nanobots for diagnosing cancer	$7.32M	prostate-cancer-research.org.uk, Earlymarket ... & 11 others	47/100
4th	C the Signs 2016, London (United Kingdom), Series A	Platform offering cancer prediction system for early cancer detection	$14.9M	Khosla Ventures, Mainspring Fund Services	44/100
5th	inveox 2017, Munich (Germany), Series A	Manufacturing automated laboratory solutions for biopsy sample preparation	$25.8M	Kacu Systemic, Integration Success & 7 others	41/100
6th	Pathware 2003, Seattle (United States), Series A	Developer of cloud-based imaging and sample management platform	$8.46M	UnityPoint Health Ventures, Level Eight Ventures ... & 13 others	41/100
7th	Thynk Health 2014, Lexington (United States), Acquired	Provider of lung cancer screening platform	$2.49M	Bluegrass Angels, Global Equity Ventures & 1 others	41/100
8th	WittGenBiotechnologies 2023, Berkeley (United States), Seed	AI-driven software for single-cell RNA sequencing cancer test analysis	$180K	-	33/100
9th	Owl Peak Technologies 2019, Charlottesville (United States), Unfunded	Platform offering solutions for early cancer detection through imaging and ML technology	-	-	30/100
10th	Insight Medbotics 2017, Hamilton (Canada), Seed	Breast cancer diagnosis and decision-making device for the healthcare professional	$435K	McMaster University	29/100